Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05690828 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Evaluation of Cognitive Management for Chemobrain in Patients Treated for Breast Cancer.

Study acronym: e-ONCOGITE
StatusActive, Not Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Study completion date: Mar 31, 2025 to Mar 31, 2026v5
  2. Trial status: Recruiting to Active, Not Recruiting
    • Primary completion date changed from estimate of Jun 1, 2024 to Oct 30, 2024
    • Study completion date: Dec 1, 2024 to Mar 31, 2025
    • Site details revised
    v4
  3. Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 0 to 1
    v3
  4. Study description expanded, about 181 wordsv2
  5. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Institut Bergonié
40 trials monitored
See 1 trial at risk
Breast Cancer
5,418 trials monitored
See 296 trials at risk
This project will investigate the efficacy of a cognitive remediation programme in patients treated for breast cancer. patients will be randomized between "no intervention" and "intervention programme". Efficay will be assessed in term of improved quality of life.
Trial Details
NCT Number NCT05690828
Lead Sponsor Institut Bergonié
Collaborators: University of Bordeaux, Association Oncogite
Conditions
(from sponsor)		 Breast Cancer
Related terms Breast Neoplasms
Enrollment 164 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov